• 제목/요약/키워드: Wang

검색결과 13,764건 처리시간 0.04초

인성교육 실현을 위한 교수.학습 과정안 및 학습자료 개발 - 중학교 기술.가정교과의 가정생활 영역을 중심으로 - (Development of teaching-learning plans and materials for character education in middle school home economics classes)

  • 이연숙;채정현;유태명;왕석순;이은희;유난숙;박미정;김성교;이경숙;김영애;이지연;구지은;손주영;유세종
    • 한국가정과교육학회지
    • /
    • 제25권3호
    • /
    • pp.39-60
    • /
    • 2013
  • 본 연구는 중학교 기술 가정 교육과정 중 가정생활 영역의 내용을 중심으로 인성교육을 실현하기 위한 실천적 문제 중심 교수 학습과정안과 학습자료를 개발하는 데 목적이 있다. 인성교육을 실현하기 위한 인성교육 구성요소(진실성, 존중, 책임, 공정성, 배려, 시민의식)를 결정하고, 중학교 기술 가정 교육과정 중 가정생활 영역의 내용 분석을 통해 21개의 실천적 문제를 도출하였다. 이를 통해 실천적 문제 해결 과정을 포함한 가정과 교수 학습과정안과 학습자료를 개발하였으며 본문에서는 이 중 두개의 교수 학습과정안과 학습자료를 실례로 보여주었다. 개발된 교수 학습과정안과 학습자료의 평가 결과, 학습자료 적합성은 5점 만점에 평균 4.28, 실천문제 적합성은 평균 4.32를 받아 타당성을 확보하여 적합하게 개발된 것으로 나타났다. 이들 자료는 가정과수업을 통해 인성교육을 실현하는 데 활용되어 가정과 교실 현장에 실제적인 도움을 줄 것으로 기대된다. 가정교과는 매일의 일상적인 문제의 해결과정에서 필수적으로 가치의 문제를 다룬다는 점에서 인성교육을 실현하기에 매우 적합한 교과라는 것이 확인되었다. 본 연구에서 개발된 교수 학습 과정안은 개발된 안의 타당성을 평가하는 데 그쳤지만 추후 연구에서는 이를 현장에 적용하여 실제로 이 프로그램이 중학생의 인성교육을 실현하기에 적합한지를 평가하는 연구가 있어야 할 것이다.

  • PDF

HPLC를 이용한 Isoproturon, Phenmedipham, Pyridate 및 Nitenpyram 4종 성분의 잔류농약 분석법 개발 (Analysis of Four Pesticides, Isoproturon, Phenmedipham, Pyridate and Nitenpyram Residues by High-Performance Liquid Chromatography with Diode-Array Detector)

  • 양성용;구윤창;;허경;김형국;안은미;신한승;이진원;이광원
    • 한국식품영양과학회지
    • /
    • 제39권8호
    • /
    • pp.1165-1170
    • /
    • 2010
  • Bis-carbamate계(phenmedipham), urea계(isoproturon), thiocarbamate계(pyridate) 및 vinyllidenediamine계(nitenlyram) 4종의 농약을 HPLC를 이용하여 분석하는 방법을 개발하였다. 사용된 칼럼은 C-18($250\;mm{\times}4.6\;mm$, $5\;{\mu}m$ diameter particle size)이며 isoproturon, phenmedipham은 acetonitrile과 물을 50:50으로 섞어서 사용하였으며, pyridate는 acetonitrile과 물을 85:15로, nitenpyram은 phosphoric acid를 이용하여 pH 2.5로 맞춘 50 mM $KH_2PO_4$와 acetonitrile을 90:10으로 섞어 유속 1 mL/min의 isocratic 조건으로 분석하였다. 시료 주입량은 $10\;{\mu}L$이며 retention time은 isoproturon 6.12분, phenmedipham 8.63분, pyridate 9.40분, nitenpyram 12.76분, 정량한계는 모두 0.05 mg/kg이었다. 회수율 실험은 쌀, 사과 및 대두에 4종의 농약 표준품을 각각 0.05, 0.1 및 0.5 mg/kg이 되도록 세 가지 농도로 spiking 하였으며, 회수율 및 분석오차는 70.18~118.08% 범위와 10% 이내를 만족하였다.

Transcatheter Arterial Chemoembolization Combined with Interferon-α is Safe and Effective for Patients with Hepatocellular Carcinoma after Curative Resection

  • Zuo, Chaohui;Xia, Man;Liu, Jingshi;Qiu, Xiaoxin;Lei, Xiong;Xu, Ruocai;Liu, Hanchun;Li, Jianliang;Li, Yongguo;Li, Qinglong;Xiao, Hua;Hong, Yuan;Wang, Xiaohong;Zhu, Haizhen;Wu, Qunfeng;Burns, Michael;Liu, Chen
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권1호
    • /
    • pp.245-251
    • /
    • 2015
  • Objectives: Intrahepatic recurrence is the major cause of death among patients with hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) after curative surgical resection. Several approaches have been reported to decrease the recurrence rate. The objective of our study was to compare the clinical effects of transcatheter arterial chemoembolization (TACE) combined with interferon-alpha (IFN-${\alpha}$) therapy on recurrence after hepatic resection in patients with HBV-related HCC with that of TACE chemotherapy alone. Methods: We retrospectively analyzed the data from 228 patients who were diagnosed with HBV-related HCC and underwent curative resection between January 2001 to December 2008. The patients were divided into TACE (n = 126) and TACE-IFN-${\alpha}$ (n = 102) groups for postoperative chemotherapy. The TACE regimen consisted of 5-fluorouracil (5-FU), cisplatin (DDP), and the emulsion mixed with mitomycin C (MMC) and lipiodol. The recurrence rates, disease-free survival (DFS), overall survival (OS), and risk of recurrence were evaluated. Results: The clinicopathological parameters and adverse effects were similar between the 2 groups (P > 0.05). The median OS for the TACE-IFN-${\alpha}$ group (36.3 months) was significantly longer than that of the TACE group (24.5 months, P < 0.05). The 3-and 5-year OS for the TACE-IFN-${\alpha}$ group were significantly longer than those of the TACE group (P < 0.05) and the recurrence rate was significantly lower (P < 0.05). The TACE and IFN-${\alpha}$ combination therapy, active hepatitis HBV infection, the number of tumor nodules, microvascular invasion, liver cirrhosis, and the BCLC stage were independent predictors of OS and DFS. Conclusions: The use of the TACE and IFN-${\alpha}$ combination chemotherapy after curative hepatic resection safely and effectively improves OS and decreases recurrence in patients with HBV-related HCC who are at high risk. Our findings can serve as a guide for the selection of postoperative adjuvant chemotherapy for patients with HBV-related HCC who are at high risk of recurrence.

Weight Loss Correlates with Macrophage Inhibitory Cytokine-1 Expression and Might Influence Outcome in Patients with Advanced Esophageal Squamous Cell Carcinoma

  • Lu, Zhi-Hao;Yang, Li;Yu, Jing-Wei;Lu, Ming;Li, Jian;Zhou, Jun;Wang, Xi-Cheng;Gong, Ji-Fang;Gao, Jing;Zhang, Xiao-Tian;Li, Jie;Li, Yan;Shen, Lin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권15호
    • /
    • pp.6047-6052
    • /
    • 2014
  • Background: Weight loss during chemotherapy has not been exclusively investigated. Macrophage inhibitory cytokine-1 (MIC-1) might play a role in its etiology. Here, we investigated the prognostic value of weight loss before chemotherapy and its relationship with MIC-1 concentration and its occurrence during chemotherapy in patients with advanced esophageal squamous cell carcinoma (ESCC). Materials and Methods: We analyzed 157 inoperable locally advanced or metastatic ESCC patients receiving first-line chemotherapy. Serum MIC-1 concentrations were assessed before chemotherapy. Patients were assigned into two groups according to their weight loss before or during chemotherapy:>5% weight loss group and ${\leq}5%$ weight loss group. Results: Patients with weight loss>5% before chemotherapy had shorter progression-free survival period (5.8 months vs. 8.7 months; p=0.027) and overall survival (10.8 months vs. 20.0 months; p=0.010). Patients with weight loss >5% during chemotherapy tended to have shorter progression-free survival (6.0 months vs. 8.1 months; p=0.062) and overall survival (8.6 months vs. 18.0 months; p=0.022), and if weight loss was reversed during chemotherapy, survival rates improved. Furthermore, serum MIC-1 concentration was closely related to weight loss before chemotherapy (p=0.001) Conclusions: Weight loss both before and during chemotherapy predicted poor outcome in advanced ESCC patients, and MIC-1 might be involved in the development of weight loss in such patients.

Effects of Momordica charantia Saponins on In vitro Ruminal Fermentation and Microbial Population

  • Kang, Jinhe;Zeng, Bo;Tang, Shaoxun;Wang, Min;Han, Xuefeng;Zhou, Chuanshe;Yan, Qiongxian;He, Zhixiong;Liu, Jinfu;Tan, Zhiliang
    • Asian-Australasian Journal of Animal Sciences
    • /
    • 제29권4호
    • /
    • pp.500-508
    • /
    • 2016
  • This study was conducted to investigate the effects of Momordica charantia saponin (MCS) on ruminal fermentation of maize stover and abundance of selected microbial populations in vitro. Five levels of MCS supplements (0, 0.01, 0.06, 0.30, 0.60 mg/mL) were tested. The pH, $NH_3-N$, and volatile fatty acid were measured at 6, 24, 48 h of in vitro mixed incubation fluids, whilst the selected microbial populations were determined at 6 and 24 h. The high dose of MCS increased the initial fractional rate of degradation at t-value = 0 ($FRD_0$) and the fractional rate of gas production (k), but decreased the theoretical maximum of gas production ($V_F$) and the half-life ($t_{0.5}$) compared with the control. The $NH_3-N$ concentration reached the lowest concentration with 0.01 mg MCS/mL at 6 h. The MSC inclusion increased (p<0.001) the molar proportion of butyrate, isovalerate at 24 h and 48 h, and the molar proportion of acetate at 24 h, but then decreased (p<0.05) them at 48 h. The molar proportion of valerate was increased (p<0.05) at 24 h. The acetate to propionate ratio (A/P; linear, p<0.01) was increased at 24 h, but reached the least value at the level of 0.30 mg/mL MCS. The MCS inclusion decreased (p<0.05) the molar proportion of propionate at 24 h and then increased it at 48 h. The concentration of total volatile fatty acid was decreased (p<0.001) at 24 h, but reached the greatest concentration at the level of 0.01 mg/mL and the least concentration at the level of 0.60 mg/mL. The relative abundance of Ruminococcus albus was increased at 6 h and 24 h, and the relative abundance of Fibrobacter succinogenes was the lowest (p<0.05) at 0.60 mg/mL at 6 h and 24 h. The relative abundance of Butyrivibrio fibrisolvens and fungus reached the greatest value (p<0.05) at low doses of MCS inclusion and the least value (p<0.05) at 0.60 mg/mL at 24 h. The present results demonstrates that a high level of MCS quickly inhibits in vitro fermentation of maize stover, while MCS at low doses has the ability to modulate the ruminal fermentation pattern by regulating the number of functional rumen microbes including cellulolytic bacteria and fungi populations, and may have potential as a feed additive applied in the diets of ruminants.

Paraoxonase 1 (PON1) Q192R Gene Polymorphism and Cancer Risk: A Meta-Analysis Based on 30 Publications

  • Zhang, Meng;Xiong, Hu;Fang, Lu;Lu, Wei;Wu, Xun;Huang, Zhan-Sen;Wang, Yong-Qiang;Cai, Zhi-Ming;Wu, Song
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제16권10호
    • /
    • pp.4457-4463
    • /
    • 2015
  • Common genetic variation Q192R in the paraoxonase 1 (PON1) gene has been considered to be implicated in the development of many cancers. Nevertheless, results from the related studies were inconsistent. To elucidate the association, we performed a meta-analysis for 8,112 cases and 10,037 controls from 32 published case-control studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association by STATA 12.0 software. Overall, we revealed that the PON1-192R allele was associated with a reduced risk of the overall cancers. Moreover, in the stratified analysis by cancer types (breast cancer, prostate cancer, brain cancer etc.), the results showed that PON1-192R allele was associated with a decreased risk in breast cancer (R vs Q: OR=0.605, 95% CI=0.378-0.967, $P_{heterogeneity}=0.000$; RR vs QQ: OR=0.494, 95% CI=0.275-0.888, $P_{heterogeneity}=0.002$; RQ vs QQ: OR=0.465, 95% CI=0.259-0.835, $P_{heterogeneity}=0.000$; and RR+RQ vs QQ: OR=0.485, 95% CI=0.274-0.857, $P_{heterogeneity}=0.000$), and associated with prostate cancer in homozygote (RR vs QQ: OR=0.475, 95% CI=0.251-0.897, $P_{heterogeneity}=0.001$) and recessive models (RR vs RQ+QQ: OR=0.379, 95% CI=0.169-0.853, $P_{heterogeneity}=0.000$), while an increased risk was identified in lymphoma (R vs Q: OR=1.537, 95% CI=1.246-1.896, $P_{heterogeneity}=0.944$; RR vs QQ: OR=2.987, 95% CI=1.861-4.795, $P_{heterogeneity}=0.350$; RR+RQ vs QQ: OR=1.354, 95% CI=1.021-1.796, $P_{heterogeneity}=0.824$; and RR vs RQ+QQ: OR=2.934, 95% CI=1.869-4.605, $P_{heterogeneity}=0.433$), and an increased risk in prostate cancer under heterozygote comparison (RQ vs QQ: OR=1.782, 95% CI=1.077-2.950, $P_{heterogeneity}=0.000$) and dominant models (RR+RQ vs QQ: OR=1.281, 95% CI=1.044-1.573, $P_{heterogeneity}=0.056$). When subgroup analysis that performed by the control source (hospital based or population based), a decreased risk of the overall cancers was revealed by homozygote (RR vs QQ: OR=0.601, 95% CI=0.366-0.987, $P_{heterogeneity}=0.000$) and dominant models (RR vs RQ+QQ: OR= 0.611, 95% CI=0.384-0.973, $P_{heterogeneity}=0.000$) in hospital based group. Stratifying by ethnicity, a significantly reduced risk of the overall cancers under allele contrast model (R vs Q: OR=0.788, 95% CI=0.626-0.993, $P_{heterogeneity}=0.000$) was uncovered in Caucasian. In summary, these findings suggested that PON1 Q192R polymorphism was associated with a reduced risk of the overall cancers, nevertheless, it might increase cancer susceptibility of prostate and lymphoma risk. Large well-designed epidemiological studies will be continued on this issue of interest.

Clinical Implications of p57KIP2 Expression in Breast Cancer

  • Xu, Xiao-Yin;Wang, Wen-Qian;Zhang, Lei;Li, Yi-Ming;Tang, Miao;Jiang, Nan;Cai, Shou-Liang;Wei, Liang;Jin, Feng;Chen, Bo
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제13권10호
    • /
    • pp.5033-5036
    • /
    • 2012
  • Objective: To study the relationship between expression of $p57^{KIP2}$ and prognosis and other clinicopathological parameters in invasive breast cancers. Methods: We assessed the expression of $p57^{KIP2}$ in 89 cases of invasive breast cancer and 20 cases of normal breast tissue by immunohistochemical methods and analyzed the results with SPSS software (ver. 16.0). Result: The positive expression rates of $p57^{KIP2}$ protein in the invasive breast cancers and surrounding normal tissue were 30.3% (27/89) and 65% (13/20), respectively. Cases with no $p57^{KIP2}$ expression exhibited a significantly higher post-operative distant metastasis rate than those with $p57^{KIP2}$ expression (37.9% vs. 14.8%; P = 0.01). DFS analysis showed that $p57^{KIP2}$-/C-erbB-2+ tumors also exhibited a significantly higher post-operative distant metastasis rate than the other groups (66.7% vs. 29.2%; P = 0.007), as did $p57^{KIP2}$-/p53+ tumors (64.3% vs. 22.7%; P = 0.001). Survival analysis revealed that $p57^{KIP2}$ was associated with breast cancer-specific survival overall (P = 0.045, log-rank test). Subgroup analysis demonstrated that individuals with $p57^{KIP2}$-/C-erbB-2+tumors experienced significantly worse post-operative survival than those with $p57^{KIP2}$-/C-erbB-2- or other tumors (P = 0.006, log-rank test). $p57^{KIP2}$-/p53+ tumors were associated with significantly worse post-operative survival than $p57^{KIP2}$-/p53- or other tumors (P = 0.001, log-rank test). Cox regression analysis showed that $p57^{KIP2}$ was a non-independent prognostic factor for breast cancer (P = 0.303). Conclusions: $p57^{KIP2}$ is expressed at low levels in invasive breast cancer and is associated with better overall survival rate and disease-free survival in breast cancer patients, but it was a non-independent prognostic factor for breast cancer. Thus, the connection between $p57^{KIP2}$/p53 and $p57^{KIP2}$/C-erbB-2 may provide biomarkers for breast cancer.

Neutrophil Count and the Inflammation-based Glasgow Prognostic Score Predict Survival in Patients with Advanced Gastric Cancer Receiving First-line Chemotherapy

  • Li, Qing-Qing;Lu, Zhi-Hao;Yang, Li;Lu, Ming;Zhang, Xiao-Tian;Li, Jian;Zhou, Jun;Wang, Xi-Cheng;Gong, Ji-Fang;Gao, Jing;Li, Jie;Li, Yan;Shen, Lin
    • Asian Pacific Journal of Cancer Prevention
    • /
    • 제15권2호
    • /
    • pp.945-950
    • /
    • 2014
  • Purpose: To explore the value of systemic inflammatory markers as independent prognostic factors and the extent these markers improve prognostic classification for patients with inoperable advanced or metastatic gastric cancer (GC) receiving palliative chemotherapy. Methods: We studied the prognostic value of systemic inflammatory factors such as circulating white blood cell count and its components as well as that combined to form inflammation-based prognostic scores (Glasgow Prognostic Score (GPS), Neutrophil-Lymphocyte Ratio (NLR), Platelet Lymphocyte Ratio (PLR), Prognostic Index (PI) and Prognostic Nutritional Index (PNI)) in 384 patients with inoperable advanced or metastatic gastric cancer (GC) receiving first-line chemotherapy. Univariate and multivariate analyses were performed to examine the impact of inflammatory markers on overall survival (OS). Results: Univariate analysis revealed that an elevated white blood cell, neutrophil and/or platelet count, a decreased lymphocyte count, a low serum albumin concentration, and high CRP concentration, as well as elevated NLR/PLR, GPS, PI, PNI were significant predictors of shorter OS. Multivariate analysis demonstrated that only elevated neutrophil count (HR 3.696, p=0.003) and higher GPS (HR 1.621, p=0.01) were independent predictors of poor OS. Conclusion: This study demonstrated elevated pretreatment neutrophil count and high GPS to be independent predictors of shorter OS in inoperable advanced or metastatic GC patients treated with first-line chemotherapy. Upon validation of these data in independent studies, stratification of patients using these markers in future clinical trials is recommended.

금속, 흡수성 간섭 나사못 및 RIGIDfix를 이용한 전방 십자 인대 재건술의 결과 비교 (Comparison of Results of ACL Reconstruction According to the Fixation Materials (Metal & Bioabsorbable Interference Screw and RIGIDfix))

  • 임홍철;왕준호;노영진;황진호
    • 대한관절경학회지
    • /
    • 제7권2호
    • /
    • pp.206-214
    • /
    • 2003
  • 목적 : 자가 골-슬개건-골을 이용한 관절경적 전방 십자 인대 재건술시 금속성, 흡수성 간섭 나사 및 RIGIDfix를 사용하여 시행한 전방 십자 인대 재건술의 임상 결과를 비교하여 RIGIDfix 의 임상적 유용성과 안정성에 관하여 알아보고자 한다. 대상 및 방법 : 1995년 7월부터 2003년 3월 까지 고려대학교 구로병원을 내원하여 자가 골-슬개건-골을 이용한 관절경적 전방 십자 인대 재건술을 시행받은 133명을 대상으로 하였다. 제1 군은 대퇴터널을 금속성 간섭 나사못을 이용하여 고정한 44명, 제 2군은 흡수성 간 섭나사를 사용한 47명, 제 3군은 RIGIDfix 를 사용한 42명으로 하였다. 세 군 사이의 수술 전 후로 Lysholm score, KT-2000 arthrometer, pivot shift test, anterior drawer test, Lachman test 그리고 방사선학적으로는 터널의 위치 및 크기 증가를 측정하였다. 통계학적으로 SAS 8.2를 이용한 Ducan, Tukey 및 t-test를 사용하여 검증하였다 (p<0.05). 결과 : 이학적 검사상 제 1군은 1례, 제 2군은 4례에서 불안정성을 보여 주었으며, 제 3군의 경우 불안정성을 보여주는 경우는 없었다. Lysholm score는 제1군$\~$3군에서 각 각 수술 전 59.8점, 64.4.점, 61점에서 수술 후 90.1점, 92.3점 92점으로 향상되었으며 차이는 없었다. KT-2000 arthrometer의 경우도 각각 수술 전 평균 $9.20{\pm}11.87 mm$, $10.2{\pm}1.50 mm$, $9.5{\pm}1.53 mm$에서 수술 후 $1.43{\pm}0.87 mm$, $1.62{\pm}0.69 mm$, $2.00{\pm}0.74 mm$ 으로 통계학적 유의성은 없었다 (P=0.478) 일반 방사선상 대퇴 터널의 변화는 흡수성 나사(2군)를 사용한 8례에서 관찰되었으나 이차 자기 공명 촬영상 2군 20례 모두에서 이식물 주변으로의 신호강도 변화를 보여 주었다. 그러나 임상적 결과와의 상관성은 찾을 수 없었다. 결론 : 관절경적 전방 십자 인대 재건술 시 금속성, 흡수성 간섭 나사 및 RIGIDfix 를 이용한 이식건의 고정에 있어서 차이는 없었다. 그러나, 대퇴 터널의 변화에 있어서는 RIGIDfix 군에 비해 금속성 및 흡수성 간섭 나사군에서 더 많이 나타났다. 따라서, 수술 도중 수기의 편함, 시간의 단축과 간섭 나사의 고정 위치, 수술 후 생물학적 반응 및 터널의 이차적 변화 등을 고려할때, RIGIDfix의 사용이 유용하리라 사료되나, 좀 더 많은 추적 기간이 필요하리라 사료된다.

  • PDF

웹기반 청각장애인용 수화 웹페이지 제작 시스템 (Web-based Text-To-Sign Language Translating System)

  • 박성욱;왕보현
    • 한국지능시스템학회논문지
    • /
    • 제24권3호
    • /
    • pp.265-270
    • /
    • 2014
  • 소리가 잘 들리지 않는 청각장애인은 소리를 표시하는 글자를 익히고 복잡한 개념을 전달하는 글을 이해하는 데 어려움이 많다. 그래서 자연스럽게 표정, 몸짓, 손짓으로 의사를 전달하는 수화가 청각장애인들의 주요 의사소통수단으로 자리잡아왔지만 사회에서는 글과 말이 주요 정보전달 수단으로 이용되고 있어 청각장애인이 정보에 접근하고 지식을 넓혀 직업을 갖는데 큰 어려움이 있다. 특히 근래에 인터넷이 보편화됨에 따라 정상인의 정보 습득량은 크게 늘었지만, 글로 표현된 인터넷을 이해하기 어려운 청각장인들은 인터넷 정보에 접근하는데 어려움이 많다. 본 연구에서는 청각장애인을 위한 수화 웹페이지를 제작할 수 있는 수화 웹페이지 제작시스템을 개발하였다. 수화 웹페이지 제작 시스템은 청각장애인용 수화 웹페이지 제작자가 통상적인 인터넷 사용에 필요한 하드웨어 및 소프트웨어 환경만 갖추면 운영할 수 있도록 웹기반으로 개발하였다. 수화용 웹 페이지 제작자는 게시판 형태의 인터페이스를 이용하여 변역하고자하는 문장을 서버에 전송할 수 있다. 서버는 수신된 문장을 수화로 번역하여 3D 아바타 기반의 수화 그래픽 애니메이션을 랜더링한다. 수화 그래픽 애니메이션은 MP4 형식의 동영상으로 변환되며, 스트리밍 서버의 저장소에 보관된다. 저장된 수화 동영상의 이름과 주소는 수화 웹페이지 제작자가 처음 문장을 입력하였던 게시판에 표시되도록 하여 향후 청각장애인용 웹 페이지를 제작할 때 활용할 수 있도록 하였다. 또한 본 연구에서는 웹페이지 제작자가 공공기관의 웹페이지를 제작할 수 있도록, 이들 기관에서 현재 사용된 글들을 수화로 번역할 때 필요한 수화 단어를 수화 웹페이지 제작 시스템의 수화 사전에 추가하였다. 수화 단어를 추가함으로써 웹기반 수화 웹페이지 제작 시스템이 공공부문에 보다 더 많이 활용될 수 있을 것이다.